483
Catalent CTS, LLCCatalent CTS, LLC – FDA 483, Nov 10, 2014
Record Details
An FDA inspection of Catalent CTS (Kansas City), LLC identified significant deficiencies in the manufacturing and control of Lomitapide capsules. The firm failed to adequately validate analytical methods, establish proper control procedures for wet granulation, and maintain complete master batch records. Additionally, the company did not thoroughly investigate out-of-trend results, indicating a lack of robust quality oversight.
View Company Profile
ID · 5793ba1a-48e1-44ab-9e6e-522ce99e4293
Other documents for Catalent CTS, LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.